Close

Are you in compliance?

Don't miss out! Sign up today for our weekly newsletters and stay abreast of important GRC-related information and news.

×

Status message

Start your free, no obligation 5-day trial to continue exploring with full access.

Pfizer Names Executive Leadership Team Following Allergan Merger

Scuttlebutt | February 12, 2016

Pfizer this month announced the executive leadership team for the combined Pfizer and Allergan business, following the close of the proposed transaction.

As previously announced, Brent Saunders will become president and chief operating officer of the combined company with responsibility for the oversight of Pfizer and Allergan’s combined commercial businesses, manufacturing and strategy functions.

Effective immediately and through the closing of the transaction Pfizer’s Global Innovative Pharma (GIP) business and its Vaccines, Oncology and Consumer (VOC) business will operate separately under the leadership of Albert Bourla, currently group president, VOC. Upon the closing of the transaction, the Vaccines and Oncology businesses will be combined with the GIP business, and Albert Bourla...

Buy this article for $49, or subscribe to Compliance Week for a month at $149 and get unlimited article access for 30 days.